Olivier Vaute

Olivier Vaute has extensive work experience in the biopharmaceutical industry. Olivier is currently serving as the Director of Operations at Evolve Biologics since September 2021. Prior to this role, they held the position of Director Program Management from January to October 2021, and Senior Program Manager from April 2018 to January 2021 at the same company.

Before joining Evolve Biologics, Olivier worked at Therapure Biopharma Inc as a Program Manager from August 2013 to April 2018.

Prior to that, they held the role of Director Product Development & Business Analysis at Viventia Biotech from October 2011 to July 2013. In this role, they were responsible for product development and evaluating products in the Antibody Drug Conjugate field.

From April 2008 to December 2011, Olivier worked at Pharmanet Canada, Inc as a Project Manager. Olivier managed multiple projects in the Phase IIa, Phase I, Bioequivalence, and Bioanalytical stages.

Olivier's career began at Irdi-Icso Group in France, where they worked as a Venture Capital Analyst from April 2006 to October 2006. Olivier evaluated technological projects in biotechnology and ICT and developed a valuation procedure for company fair value assessment.

Olivier also worked as a Research Project Manager at LBME-CNRS from September 2000 to March 2005. Additionally, Olivier served as a Teacher in Molecular Biology at Paul Sabatier University in France from September 2001 to June 2004.

Olivier Vaute completed their Master's degree in Molecular Biology at Université Paul Sabatier Toulouse III. Olivier then pursued further education and obtained a Ph.D. in Molecular Biology from the same university. Eventually, they went on to attend Toulouse Business School for an MBA with a focus on Biotechnology management.